Neuphoria Therapeutics Inc. (NEUP) vs NextCure, Inc. (NXTC)
A side-by-side comparison of Neuphoria Therapeutics Inc. and NextCure, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
NEUP
Neuphoria Therapeutics Inc.
$3.48HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
NXTC
NextCure, Inc.
$5.58HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Total return — NEUP vs NXTC
growth of $100 · dividends reinvested · last 5yNEUP -98.0% (-54.5%/yr)NXTC -92.6% (-40.6%/yr)NXTC compounded faster over this window
NEUP NXTC
NEUP vs NXTC: by the numbers
- •NXTC is the larger company ($20M vs $19M market cap).
- •Both run net losses; NXTC's is the smaller (0.00% vs -1578.40% net margin).
Metrics side by side
Valuation
| Metric | NEUP | NXTC |
|---|---|---|
| P/S ratio | 16.02 | N/A |
| P/B ratio | 0.76 | 1.66 |
Profitability
| Metric | NEUP | NXTC |
|---|---|---|
| Gross margin | 43.54% | 0.00% |
| Operating margin | -835.53% | 0.00% |
| Net margin | -1578.40% | 0.00% |
| ROE | -75.34% | -351.86% |
| ROIC | -49.83% | -259.91% |
Growth (annualized)
| Metric | NEUP | NXTC |
|---|---|---|
| Revenue CAGR (5Y) | 11.12% | N/A |
| Total return CAGR (5Y) | N/A | -44.29% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.